Q3 2024 · CIK 1489933 Snapshot · — Export CSV
Manager file · GLRE · DME Capital Management, LP

David Einhorn - Greenlight Capital

EDGAR CIK 1489933 ↗ · Waiting · typical filing lag 45 days · EDGAR name DME Capital Management, LP (Greenlight Capital, David Einhorn); Greenlight Capital Inc (1079114) last 13F 2024-02-14

Export CSV
Reported portfolio value
$2.40B
QoQ reported +17.5% · vs Q2 2024
Positions
38
1 new · 2 exited
Top 10 concentration
74.0%
largest position 32.9%
Position churn · Q3 2024
13 added · 8 trimmed
new positions 3.3% · exits 0.0% of book
Holdings · Q3 2024 · 38
Security Weight Δ wt Price* Shares Δ shares Value Action
1 GRBK GREEN BRICK PARTNERS INC 32.91% +3.6% $84 9.47M -9.6% $791M Trimmed
2 — CONSOL ENERGY INC NEW 7.15% -1.0% $105 1.64M +0.0% $172M Held
3 BHF BRIGHTHOUSE FINL INC 5.42% -0.9% $45 2.89M -2.7% $130M Trimmed
4 HPQ HP INC 5.27% -0.5% $36 3.53M +4.7% $127M Added
5 KD KYNDRYL HLDGS INC 4.71% -1.0% $23 4.92M +11.0% $113M Added
6 PENN PENN ENTERTAINMENT INC 4.41% -0.4% $19 5.62M +10.3% $106M Added
7 — LIBERTY GLOBAL LTD 3.74% +2.0% $21 4.25M +108.3% $89.78M Added
8 ALITEUR ALIGHT INC 3.65% -0.3% $7 11.85M +7.0% $87.66M Added
9 VTRS VIATRIS INC 3.51% -0.3% $12 7.27M -1.7% $84.41M Trimmed
10 — CNH INDL N V 3.28% +3.3% $11 7.10M new $78.78M New
11 — ROIVANT SCIENCES LTD 2.55% +0.1% $12 5.31M +10.3% $61.25M Added
12 TECK TECK RESOURCES LTD 2.36% -0.2% $52 1.09M +0.0% $56.77M Held
13 GLD SPDR GOLD TR 2.11% -0.0% $243 209K +3.1% $50.72M Added
14 — DHT HOLDINGS INC 1.99% -0.3% $11 4.34M +7.9% $47.91M Added
15 THC TENET HEALTHCARE CORP 1.99% -1.9% $166 287K -52.0% $47.72M Trimmed
16 ODP1 THE ODP CORP 1.98% -2.3% $30 1.60M -28.0% $47.60M Trimmed
17 — CAPRI HOLDINGS LIMITED 1.92% +0.8% $42 1.09M +58.7% $46.12M Added
18 PTON PELOTON INTERACTIVE INC 1.86% +0.7% $5 9.53M +40.4% $44.60M Added
19 PPLI IAC INC 1.43% +0.8% $54 636K +118.3% $34.24M Added
20 — LIVANOVA PLC 1.32% -0.4% $53 604K -6.3% $31.71M Trimmed
21 GPK GRAPHIC PACKAGING HLDG CO 1.29% -0.5% $30 1.05M -25.0% $30.98M Trimmed
22 — SEADRILL 2021 LTD 0.99% -0.4% $40 602K +5.6% $23.91M Added
23 PPA INVESCO EXCHANGE TRADED FD T 0.87% -0.0% $115 183K +0.0% $20.98M Held
24 XAR SPDR SER TR 0.84% -0.0% $157 128K +0.0% $20.07M Held
25 — WEATHERFORD INTL PLC 0.63% -0.4% $85 177K +0.0% $15.06M Held
26 LKFT GALAPAGOS NV 0.57% +0.3% $29 479K +104.1% $13.80M Added
27 COYA COYA THERAPEUTICS INC 0.34% -0.0% $6 1.27M +0.0% $8.22M Held
28 TEVAN TEVA PHARMACEUTICAL INDS LTD 0.24% -0.0% $18 325K +0.0% $5.85M Held
29 GDX VANECK ETF TRUST 0.18% -0.0% $40 111K +0.0% $4.44M Held
30 GPRO GOPRO INC 0.16% -0.0% $1 2.82M +0.0% $3.84M Held
31 OIH VANECK ETF TRUST 0.13% -0.0% $284 11K +0.0% $3.18M Held
32 FCG FIRST TR EXCHANGE-TRADED FD 0.07% -0.0% $24 71K +0.0% $1.68M Held
33 PDBC INVESCO ACTVELY MNGD ETC FD 0.07% -0.0% $13 117K +0.0% $1.58M Held
34 GANX GAIN THERAPEUTICS INC 0.04% +0.0% $2 566K +0.0% $1.01M Held
35 — DANIMER SCIENTIFIC INC 0.02% -0.1% $0 1.10M -59.9% $498K Trimmed
36 NUVB NUVATION BIO INC 0.00% -0.0% $2 35K +0.0% $80.14K Held
37 NUVB/WS NUVATION BIO INC 0.00% -0.0% $0 100K +0.0% $9.79K Held
38 — KATAPULT HOLDINGS INC 0.00% -0.0% $0 262K +0.0% $1.50K Held
39 SHC SOTERA HEALTH CO 0.00% -0.2% — 0 300K → 0 $0 Exited
40 — TALIS BIOMEDICAL CORP 0.00% -0.1% — 0 149K → 0 $0 Exited

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • CNH INDL N V 3.28% · $78.78M
  • SOTERA HEALTH CO was 0.17% · 300K sh
  • TALIS BIOMEDICAL CORP was 0.06% · 149K sh
  • Filing detail
    Period2024-09-30
    Accepted14 Nov 2024 · 16:25 ET
    Filing lag45 days
    Form13F-HR
    Information rows79
    Quarters on file10
    Portfolio value
    Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026$3.91B Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 202646
    Quarterly history · 10 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q2 2026 2026-06-30 $3.91B 46 19.4% 7 6 14 Aug 2026 ET 45
    Q1 2026 2026-03-31 $3.19B 45 19.1% 11 7 15 May 2026 ET 45
    Q4 2025 2025-12-31 $2.85B 41 20.8% 8 4 17 Feb 2026 ET 48
    Q3 2025 2025-09-30 $2.54B 37 27.5% 4 1 14 Nov 2025 ET 45
    Q2 2025 2025-06-30 $2.33B 34 25.6% 4 3 14 Aug 2025 ET 45
    Q1 2025 2025-03-31 $1.97B 33 28.0% 2 5 15 May 2025 ET 45
    Q4 2024 2024-12-31 $1.94B 36 27.5% 5 7 14 Feb 2025 ET 45
    Q3 2024 2024-09-30 $2.40B 38 32.9% 1 2 14 Nov 2024 ET 45
    Q2 2024 2024-06-30 $2.04B 39 29.3% 3 6 14 Aug 2024 ET 45
    Q1 2024 2024-03-31 $2.18B 42 28.9% — — 15 May 2024 ET 45
    Track record · return since filing
    Paper return of each reported book
    Since Q1 2024
    +10.0%
    S&P 500 +44.3%
    Hit rate · latest book
    32%
    priced positions with positive return
    Priced coverage
    85%
    of reported stock value
    Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q2 2026 -8.3% -4.1% -4.1% 85% ACHC +24.7%
    Q1 2026 +5.5% +0.9% +4.5% 86% VSXY +119.9%
    Q4 2025 +2.0% +9.6% -7.6% 80% CNC +81.4%
    Q3 2025 +5.2% +11.7% -6.5% 81% VSXY +183.2%
    Q2 2025 +4.5% +16.7% -12.2% 78% CNC +177.8%
    Q1 2025 +4.0% +27.8% -23.8% 78% VTRS +150.4%
    Q4 2024 -5.6% +24.1% -29.7% 71% VTRS +106.4%
    Q3 2024 -4.4% +28.0% -32.4% 71% VTRS +78.2%
    Q2 2024 +6.1% +40.1% -34.0% 71% VTRS +99.3%
    Q1 2024 +10.0% +44.3% -34.2% 70% THC +118.7%
    Copy-trade simulation
    Hypothetical strategy
    +11.5%
    10 rebalances
    S&P 500 same window
    +44.3%
    excess -32.7%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.